5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost

Market sentiment has improved following President Trump's decision to delay EU tariffs until July 9 and a surge in May consumer confidence driven by progress in U.S.-China trade negotiations. Zacks has identified five broker-favored stocks—Beyond (BYON), BrightSpring Health Services (BTSG), Air Canada (ACDVF), Emergent BioSolutions (EBS), and Adient Plc (ADNT)—using a screen based on broker recommendations, earnings estimate revisions, and price-to-sales ratio, suggesting potential opportunities in these names.

Analysis

Recent market optimism, fueled by President Trump's decision to delay tariffs on EU goods until July 9 and a notable surge in May consumer confidence linked to progress in U.S.-China trade negotiations, has created a favorable investment backdrop. Against this macroeconomic landscape, a specific stock screening methodology focusing on improving broker recommendations, upward earnings estimate revisions over the past four weeks, and a low price-to-sales ratio has identified several companies. Among the highlighted stocks, Beyond (BYON), an e-commerce retailer, carries a Zacks Rank #2 (Buy) and has beaten earnings estimates in two of the last four quarters with an average beat of 3.7%. BrightSpring Health Services (BTSG), a provider of home and community-based health solutions, also holds a Zacks Rank #2 (Buy), with its 2025 earnings growth projected at 82.1% and 2025 revenue expected to increase 9.1% from 2024 actuals. Air Canada (ACDVF) is benefiting from strong air travel demand and lower fuel costs, with its Zacks Consensus Estimate for 2026 sales and earnings up 5.6% and 25.7% year-over-year, respectively, and current-year earnings estimates revised up 2.1% in the past seven days, though it carries a Zacks Rank #3 (Hold). Emergent BioSolutions (EBS), heavily reliant on U.S. government vaccine contracts which poses a concentration risk, has a strong earnings surprise history, beating estimates in three of the last four quarters by an average of 49.9%, and holds a Zacks Rank #3 (Hold). Adient Plc (ADNT), an automotive seating supplier with a strong market position, also beat earnings estimates in three of the past four quarters with an average beat of 18.3% and is rated Zacks Rank #3 (Hold). The screening criteria also included price above $5, significant average daily volume, and a market capitalization within the top 3000.

Key Decisions for Investors

• Investors should note the improved market sentiment stemming from tariff delays and strong consumer confidence, which may support equities, but focus on the specific attributes of companies identified through fundamental and sentiment-based screening.
• Consider positions in Beyond (BYON) and BrightSpring Health Services (BTSG) given their Zacks #2 (Buy) ratings, positive analyst sentiment reflected in the screen, and, for BTSG, a robust forward-looking earnings growth projection of 82.1% for 2025.
• Exercise a more cautious, hold-rated approach for Air Canada (ACDVF), Emergent BioSolutions (EBS), and Adient (ADNT), monitoring Air Canada for sustained travel demand, EBS for contract renewals given its government revenue dependency, and Adient for automotive sector cyclicality, despite their positive earnings surprise histories.
• Evaluate the described screening methodology, which prioritizes strong broker recommendations, upward earnings estimate revisions, and favorable price-to-sales ratios, as a potential framework for identifying undervalued companies with positive momentum.